POAI
Predictive Oncology Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$4.91
+6.28%Margins
Gross margin
31.8%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-591.9%
Return on equity
-527.1%
Return on assets
-81.2%
Return on invested capital
0.00x
Asset turnover
-$12.5M
Cash from operations
$9.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026